Skip to main content

Advertisement

SpringerLink
Log in

18F-FDG and 18F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Purpose

There is currently no single modality for accurate characterization of enlarged mediastinal lymph nodes into benign or malignant. Recently 18F-fluorothymidine (FLT) has been used as a proliferation marker. In this prospective study, we examined the role of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) and 18F-FLT PET/CT in categorizing mediastinal lymph nodes as benign or malignant.

Materials and methods

A total of 70 consecutive patients with mediastinal lymphadenopathy detected on computed tomography (CT) or chest radiograph underwent whole body 18F-FLT PET/CT and 18F-FDG PET/CT (within 1 week of each other). Lymph nodal tracer uptake was determined by calculation of standardized uptake value (SUV) with both the tracers. Results of PET/CT were compared with histopathology of the lymph nodes.

Results

Histopathology results showed thirty-seven patients with sarcoidosis, seven patients with tuberculosis, nine patients with non-small cell lung cancer, five patients with Hodgkin’s lymphoma and twelve patients with non-Hodgkin’s lymphoma. The mean FDG SUVmax of sarcoidosis, tuberculosis, Hodgkin’s and non-Hodgkin’s lymphoma was 12.7, 13.4, 8.2, and 8.8, respectively, and the mean FLT SUVmax was 6.0, 5.4, 4.4, and 3.8, respectively. It was not possible to characterize mediastinal lymphadenopathy as benign or malignant solely based on FDG SUVmax values (p > 0.05) or FLT SUVmax values (p > 0.05). There was no significant difference in FDG uptake (p > 0.9) or FLT uptake (p > 0.9) between sarcoidosis and tuberculosis. In lung cancer patients, the FDG SUVmax and FLT SUVmax of those lymph nodes with tumor infiltration on biopsy was 6.7 and 3.9, respectively, and those without nodal infiltration was 6.4 and 3.7, respectively, and both the tracers were not able to characterize the nodal status as malignant or benign (p > 0.05).

Conclusion

Though 18F-FLT PET/CT and 18F-FDG PET/CT reflect different aspects of biology, i.e., proliferation and metabolism, respectively, neither tracer could provide satisfactory categorization of benign and malignant lymph nodes. The results of this study clearly suggest that differentiation of mediastinal nodes into benign and malignant solely based on SUVmax values cannot be relied upon, especially in settings where tuberculosis and sarcoidosis are common.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Goodwin RA, Shapiro JL, Thurman GH, Thurman SS, Des Prez RM. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore). 1980;59(1):1–33.

    Article  Google Scholar 

  2. Sagel SS. Common fungal diseases of the lungs. I. Coccidioidomycosis. Radiol Clin North Am. 1973;11(1):153–61.

    CAS  PubMed  Google Scholar 

  3. Manns BJ, Baylis BW, Urbanski SJ, Gibb AP, Rabin HR. Paracoccidioidomycosis: case report and review. Clin Infect Dis. 1996;23(5):1026–32.

    Article  CAS  PubMed  Google Scholar 

  4. Petrillo R, Balzarini L, Bidoli P, Ceglia E, D’Ippolito G, Tess JD, et al. Esophageal squamous cell carcinoma: MRI evaluation of mediastinum. Gastrointest Radiol. 1990;15(4):275–8.

    Article  CAS  PubMed  Google Scholar 

  5. Zerhouni EA, Rutter C, Hamilton SR, Balfe DM, Megibow AJ, Francis IR, et al. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology. 1996;200(2):443–51.

    Article  CAS  PubMed  Google Scholar 

  6. Sohn KM, Lee JM, Lee SY, Ahn BY, Park SM, Kim KM. Comparing MR imaging and CT in the staging of gastric carcinoma. AJR Am J Roentgenol. 2000;174(6):1551–7.

    Article  CAS  PubMed  Google Scholar 

  7. Curtin HD, Ishwaran H, Mancuso AA, Dalley RW, Caudry DJ, McNeil BJ. Comparison of CT and MR imaging in staging of neck metastases. Radiology. 1998;207(1):123–30.

    Article  CAS  PubMed  Google Scholar 

  8. Puri SK, Fan CY, Hanna E. Significance of extracapsular lymph node metastases in patients with head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2003;11(2):119–23.

    Article  PubMed  Google Scholar 

  9. Savage C, Zwischenberger JB. Image-guided fine needle aspirate strategies for staging of lung cancer. Clin Lung Cancer. 2000;2(2):101–10 (discussion 11–12).

    Article  CAS  PubMed  Google Scholar 

  10. Milman N, Faurschou P, Munch EP, Grode G. Transbronchial lung biopsy through the fibre optic bronchoscope. Results and complications in 452 examinations. Respir Med. 1994;88(10):749–53.

    Article  CAS  PubMed  Google Scholar 

  11. Pereira W Jr, Kovnat DM, Snider GL. A prospective cooperative study of complications following flexible fiberoptic bronchoscopy. Chest. 1978;73(6):813–6.

    Article  PubMed  Google Scholar 

  12. Varela-Lema L, Fernandez-Villar A, Ruano-Ravina A. Effectiveness and safety of endobronchial ultrasound-transbronchial needle aspiration: a systematic review. Eur Respir J. 2009;33(5):1156–64.

    Article  CAS  PubMed  Google Scholar 

  13. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med. 1996;23(10):1409–15.

    Article  CAS  PubMed  Google Scholar 

  14. Buck AC, Schirrmeister HH, Guhlmann CA, Diederichs CG, Shen C, Buchmann I, et al. Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity? J Nucl Med. 2001;42(5):721–5.

    CAS  PubMed  Google Scholar 

  15. Tehrani OS, Shields AF. PET imaging of proliferation with pyrimidines. J Nucl Med. 2013;54(6):903–12.

    Article  CAS  PubMed  Google Scholar 

  16. Yamamoto Y, Nishiyama Y, Kimura N, Ishikawa S, Okuda M, Bandoh S, et al. Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2008;35(2):236–45.

    Article  CAS  PubMed  Google Scholar 

  17. Yang W, Zhang Y, Fu Z, Yu J, Sun X, Mu D, et al. Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2010;37(7):1291–9.

    Article  PubMed  Google Scholar 

  18. Tian J, Yang X, Yu L, Chen P, Xin J, Ma L, et al. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3′-deoxy-3′-18F-fluorothymidine and 18F-FDG. J Nucl Med. 2008;49(2):186–94.

    Article  PubMed  Google Scholar 

  19. Hoshikawa H, Kishino T, Mori T, Nishiyama Y, Yamamoto Y, Inamoto R, et al. Comparison of (18) F-FLT PET and (18) F-FDG PET for detection of cervical lymph node metastases in head and neck cancers. Acta Otolaryngol. 2012;132(12):1347–54.

    Article  CAS  PubMed  Google Scholar 

  20. Schaefferkoetter JD, Carlson ER, Heidel RE. Can 3′-deoxy-3′-((18)F) fluorothymidine out perform 2-deoxy-2-((18)F) fluoro-d-glucose positron emission tomography/computed tomography in the diagnosis of cervical lymphadenopathy in patients with oral/head and neck cancer? J Oral Maxillofac Surg. 2015;73(7):1420–8.

    Article  PubMed  Google Scholar 

  21. Nakajo M, Kajiya Y, Jinguji M, Nishimata N, Shimaoka S, Nihara T, et al. Diagnostic performance of (1)(8)F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with (1)(8)F-fluorodeoxyglucose PET/CT. Eur J Nucl Med Mol Imaging. 2013;40(8):1223–32.

    Article  CAS  PubMed  Google Scholar 

  22. Kumar A, Dutta R, Kannan U, Kumar R, Khilnani GC, Gupta SD. Evaluation of mediastinal lymph nodes using F-FDG PET-CT scan and its histopathologic correlation. Ann Thorac Med. 2011;6(1):11–6.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Al-Sarraf N, Aziz R, Doddakula K, Gately K, Wilson L, McGovern E, et al. Factors causing inaccurate staging of mediastinal nodal involvement in non-small cell lung cancer patients staged by positron emission tomography. Interact CardioVasc Thorac Surg. 2007;6(3):350–3.

    Article  PubMed  Google Scholar 

  24. Takamochi K, Yoshida J, Murakami K, Niho S, Ishii G, Nishimura M, et al. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer. 2005;47(2):235–42.

    Article  PubMed  Google Scholar 

  25. Carbone RG, Penna D, Baughman RP, Lower EE. Accuracy of serial PET-CT imaging in systemic sarcoidosis. J Clin Imaging Sci. 2014;4:21.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Sobic-Saranovic DP, Grozdic IT, Videnovic-Ivanov J, Vucinic-Mihailovic V, Artiko VM, Saranovic DZ, et al. Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis. Clin Nucl Med. 2013;38(7):516–21.

    Article  PubMed  Google Scholar 

  27. Sobic-Saranovic D, Grozdic I, Videnovic-Ivanov J, Vucinic-Mihailovic V, Artiko V, Saranovic D, et al. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis. J Nucl Med. 2012;53(10):1543–9.

    Article  PubMed  Google Scholar 

  28. Maturu VN, Agarwal R, Aggarwal AN, Mittal BR, Bal A, Gupta N, et al. Dual-time point whole-body 18F-fluorodeoxyglucose PET/CT imaging in undiagnosed mediastinal lymphadenopathy: a prospective study of 117 patients with sarcoidosis and TB. Chest. 2014;146(6):e216–20.

    Article  PubMed  Google Scholar 

  29. Chilosi M, Menestrina F, Capelli P, Montagna L, Lestani M, Pizzolo G, et al. Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki67+ and interleukin-1+ cells. Am J Pathol. 1988;131(2):191–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Semenzato G, Pezzutto A, Pizzolo G, Chilosi M, Ossi E, Angi MR, et al. Immunohistological study in sarcoidosis: evaluation at different sites of disease activity. Clin Immunol Immunopathol. 1984;30(1):29–40.

    Article  CAS  PubMed  Google Scholar 

  31. Tan Y, Liang J, Liu D, Zhu F, Wang G, Ding X, et al. F-FLT PET/CT imaging in a Wister rabbit inflammation model. Exp Ther Med. 2014;8(1):69–72.

    PubMed  PubMed Central  Google Scholar 

  32. Zhao S, Kuge Y, Kohanawa M, Takahashi T, Zhao Y, Yi M, et al. Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT. J Nucl Med. 2008;49(1):135–41.

    Article  CAS  PubMed  Google Scholar 

  33. Wang R, Zhu H, Chen Y, Li C, Li F, Shen Z, et al. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT. Hematol Oncol. 2014;32(3):126–32.

    Article  CAS  PubMed  Google Scholar 

  34. Buck AK, Bommer M, Stilgenbauer S, Juweid M, Glatting G, Schirrmeister H, et al. Molecular imaging of proliferation in malignant lymphoma. Cancer Res. 2006;66(22):11055–61.

    Article  CAS  PubMed  Google Scholar 

  35. Sharma SK, Mohan A. Sarcoidosis in India: not so rare! JIACM. 2004;5(1):12–21.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and PET, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India

    Sampanna Jung Rayamajhi, Bhagwant Rai Mittal, Venkata Nagarjuna Maturu & Jaya Shukla

  2. Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India

    Ritesh Agarwal & Dheeraj Gupta

  3. Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India

    Amanjit Bal

  4. Department of Cytology and Gynaecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India

    Pranab Dey

Authors
  1. Sampanna Jung Rayamajhi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bhagwant Rai Mittal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Venkata Nagarjuna Maturu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ritesh Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amanjit Bal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pranab Dey
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jaya Shukla
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dheeraj Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bhagwant Rai Mittal.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rayamajhi, S.J., Mittal, B.R., Maturu, V.N. et al. 18F-FDG and 18F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes. Ann Nucl Med 30, 207–216 (2016). https://doi.org/10.1007/s12149-015-1047-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-015-1047-6

Keywords

Search

Navigation